FI20031191L - Monoamiinin takaisinoton estäjä - Google Patents

Monoamiinin takaisinoton estäjä Download PDF

Info

Publication number: FI20031191L
Authority: FI; Finland
Prior art keywords: reuptake inhibitor; monoamine reuptake; monoamine; inhibitor; reuptake
Prior art date: 2001-03-06

Application number

FI20031191A

Other languages

English (en)

Swedish (sv)

Other versions

FI20031191A7 (fi

Inventor

Edward Louis Mattiuz

John-Michael Sauer

William Joe Wheeler

David Taiwai Wong

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-06

Filing date

2002-02-20

Publication date

2003-08-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23045157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20031191(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-02-20 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2003-08-25 Publication of FI20031191L publication Critical patent/FI20031191L/fi

2003-08-25 Publication of FI20031191A7 publication Critical patent/FI20031191A7/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Otolaryngology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Immunology (AREA)
Hematology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI20031191A 2001-03-06 2002-02-20 Monoamiinin takaisinoton estäjä FI20031191A7 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27373001P	2001-03-06	2001-03-06
PCT/US2002/003385 WO2002070457A1 (en)	2001-03-06	2002-02-20	Inhibitor of monoamine uptake

Publications (2)

Publication Number	Publication Date
FI20031191L true FI20031191L (fi)	2003-08-25
FI20031191A7 FI20031191A7 (fi)	2003-08-25

Family

ID=23045157

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI20031191A FI20031191A7 (fi)	2001-03-06	2002-02-20	Monoamiinin takaisinoton estäjä

Country Status (35)

Country	Link
US (2)	US20040082666A1 (fi)
EP (1)	EP1379492B1 (fi)
JP (1)	JP2004525912A (fi)
KR (1)	KR20030092012A (fi)
CN (1)	CN1229331C (fi)
AP (1)	AP2003002855A0 (fi)
AT (2)	AT414238B (fi)
AU (1)	AU2002245385B2 (fi)
BR (1)	BR0207716A (fi)
CA (1)	CA2440161A1 (fi)
CH (1)	CH695982A5 (fi)
CZ (1)	CZ20032380A3 (fi)
DE (1)	DE60226715D1 (fi)
DK (1)	DK200301267A (fi)
EA (1)	EA005768B1 (fi)
EC (1)	ECSP034760A (fi)
EE (1)	EE200300419A (fi)
ES (2)	ES2201942B2 (fi)
FI (1)	FI20031191A7 (fi)
GB (1)	GB2389851B (fi)
HR (1)	HRP20030710A2 (fi)
HU (1)	HUP0303341A3 (fi)
IL (1)	IL157779A0 (fi)
LT (1)	LT5143B (fi)
LU (1)	LU91038B1 (fi)
LV (1)	LV13119B (fi)
NO (1)	NO20033921L (fi)
NZ (1)	NZ527431A (fi)
OA (1)	OA12494A (fi)
PL (1)	PL363840A1 (fi)
SE (1)	SE526598C2 (fi)
SK (1)	SK10632003A3 (fi)
TR (1)	TR200705146T1 (fi)
WO (1)	WO2002070457A1 (fi)
ZA (1)	ZA200306882B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2201942B2 (es) *	2001-03-06	2004-12-16	Eli Lilly And Company	Inhibidor de la captacion de monoamina.
US20060241188A1 (en) *	2003-08-27	2006-10-26	Elililly And Company	Treatment of pervasive developemental disorders with norepinephrine reuptake inhibitors
ATE399557T1 (de) *	2003-12-12	2008-07-15	Lilly Co Eli	Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen
WO2011027359A2 (en) *	2009-07-30	2011-03-10	Matrix Laboratories Ltd	Novel process for the preparation of 4-hydroxy atomoxetine
WO2012020418A1 (en)	2010-08-12	2012-02-16	Matrix Laboratories Ltd	Novel polymorphs of 4-hydroxy atomoxetine hydrochloride
DE102013022397A1 (de)	2013-12-19	2016-07-07	Metrax Gmbh	Vorrichtung zur Unterstützung eines Ersthelfers bei der Herzdruckmassage
GR1008819B (el)	2015-05-22	2016-08-01	Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων	Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου
CN107935848B (zh) *	2017-11-21	2020-12-22	中国农业科学院兰州畜牧与兽药研究所	一种六茜素衍生物及其制备方法和应用
CN112930179A (zh) *	2018-10-31	2021-06-08	爱普宁公司(特拉华)	治疗睡眠呼吸暂停的方法和组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4314081A (en) *	1974-01-10	1982-02-02	Eli Lilly And Company	Arloxyphenylpropylamines
US4194009A (en)	1974-01-10	1980-03-18	Eli Lilly And Company	Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4018895A (en)	1974-01-10	1977-04-19	Eli Lilly And Company	Aryloxyphenylpropylamines in treating depression
FR2432500A1 (fr) *	1978-02-24	1980-02-29	Roussel Uclaf	Nouveaux derives de la benzene propanamine et leurs sels, procede de preparation et application a titre de medicaments
US5112619A (en) *	1985-11-12	1992-05-12	Eli Lilly And Company	Orally administerable sustained release pharmaceutical formulation
US4956388A (en)	1986-12-22	1990-09-11	Eli Lilly And Company	3-aryloxy-3-substituted propanamines
ZA885824B (en) *	1987-08-14	1989-04-26	Merrell Dow Pharma	Novel antidepressants
PH30083A (en) *	1991-02-25	1996-12-27	Lilly Co Eli	Treatment of lower urinary tract disorders
TW514634B (en)	1997-10-14	2002-12-21	Lilly Co Eli	Process to make chiral compounds
AU3219800A (en)	1999-03-29	2000-10-16	Eli Lilly And Company	Stereospecific method for preparing tomoxetine and intermediates thereof
JP2002541235A (ja)	1999-04-09	2002-12-03	イーライ・リリー・アンド・カンパニー	３−アリールオキシ−３−アリールプロピルアミン及びその中間体の製造方法
PL366119A1 (en) *	2000-11-15	2005-01-24	Eli Lilly And Company	Treatment of anxiety disorders
ES2201942B2 (es) *	2001-03-06	2004-12-16	Eli Lilly And Company	Inhibidor de la captacion de monoamina.

2002
- 2002-02-20 ES ES200350052A patent/ES2201942B2/es not_active Expired - Fee Related
- 2002-02-20 AP APAP/P/2003/002855A patent/AP2003002855A0/en unknown
- 2002-02-20 GB GB0323169A patent/GB2389851B/en not_active Expired - Fee Related
- 2002-02-20 HR HR20030710A patent/HRP20030710A2/hr not_active Application Discontinuation
- 2002-02-20 OA OA1200300215A patent/OA12494A/en unknown
- 2002-02-20 CN CNB028060253A patent/CN1229331C/zh not_active Ceased
- 2002-02-20 FI FI20031191A patent/FI20031191A7/fi not_active IP Right Cessation
- 2002-02-20 EA EA200300978A patent/EA005768B1/ru not_active IP Right Cessation
- 2002-02-20 EP EP02713538A patent/EP1379492B1/en not_active Revoked
- 2002-02-20 TR TR2007/05146T patent/TR200705146T1/xx unknown
- 2002-02-20 KR KR10-2003-7011635A patent/KR20030092012A/ko not_active Ceased
- 2002-02-20 AT AT0904202A patent/AT414238B/de not_active IP Right Cessation
- 2002-02-20 PL PL02363840A patent/PL363840A1/xx not_active Application Discontinuation
- 2002-02-20 IL IL15777902A patent/IL157779A0/xx unknown
- 2002-02-20 CA CA002440161A patent/CA2440161A1/en not_active Abandoned
- 2002-02-20 CH CH01522/03A patent/CH695982A5/de not_active IP Right Cessation
- 2002-02-20 EE EEP200300419A patent/EE200300419A/xx unknown
- 2002-02-20 NZ NZ527431A patent/NZ527431A/en unknown
- 2002-02-20 US US10/468,553 patent/US20040082666A1/en not_active Abandoned
- 2002-02-20 SK SK1063-2003A patent/SK10632003A3/sk unknown
- 2002-02-20 AU AU2002245385A patent/AU2002245385B2/en not_active Ceased
- 2002-02-20 JP JP2002569778A patent/JP2004525912A/ja not_active Ceased
- 2002-02-20 DE DE60226715T patent/DE60226715D1/de not_active Revoked
- 2002-02-20 LU LU91038A patent/LU91038B1/fr active
- 2002-02-20 BR BR0207716-7A patent/BR0207716A/pt not_active IP Right Cessation
- 2002-02-20 HU HU0303341A patent/HUP0303341A3/hu unknown
- 2002-02-20 WO PCT/US2002/003385 patent/WO2002070457A1/en not_active Ceased
- 2002-02-20 CZ CZ20032380A patent/CZ20032380A3/cs unknown
- 2002-02-20 AT AT02713538T patent/ATE396170T1/de not_active IP Right Cessation
- 2002-02-20 ES ES02713538T patent/ES2305221T3/es not_active Expired - Lifetime
2003
- 2003-08-11 LT LT2003075A patent/LT5143B/lt unknown
- 2003-09-02 EC EC2003004760A patent/ECSP034760A/es unknown
- 2003-09-03 ZA ZA200306882A patent/ZA200306882B/en unknown
- 2003-09-03 SE SE0302361A patent/SE526598C2/sv not_active IP Right Cessation
- 2003-09-04 NO NO20033921A patent/NO20033921L/no not_active Application Discontinuation
- 2003-09-04 DK DK200301267A patent/DK200301267A/da not_active Application Discontinuation
- 2003-09-10 LV LVP-03-100A patent/LV13119B/en unknown
2005
- 2005-05-09 US US11/125,348 patent/US7384983B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1494526A (zh)	2004-05-05
ZA200306882B (en)	2004-12-03
EP1379492A1 (en)	2004-01-14
CA2440161A1 (en)	2002-09-12
ES2201942A1 (es)	2004-03-16
ATE396170T1 (de)	2008-06-15
ATA90422002A (de)	2006-01-15
BR0207716A (pt)	2004-03-23
SK10632003A3 (sk)	2004-06-08
CZ20032380A3 (en)	2004-03-17
WO2002070457A8 (en)	2004-06-03
TR200705146T1 (tr)	2008-02-21
AU2002245385B2 (en)	2007-01-18
LT5143B (lt)	2004-06-25
HRP20030710A2 (en)	2004-08-31
NO20033921L (no)	2003-11-05
DK200301267A (da)	2003-11-06
LT2003075A (en)	2004-03-25
EP1379492B1 (en)	2008-05-21
GB0323169D0 (en)	2003-11-05
CN1229331C (zh)	2005-11-30
IL157779A0 (en)	2004-03-28
NZ527431A (en)	2005-05-27
US20040082666A1 (en)	2004-04-29
GB2389851A (en)	2003-12-24
NO20033921D0 (no)	2003-09-04
DE60226715D1 (de)	2008-07-03
EA200300978A1 (ru)	2004-02-26
KR20030092012A (ko)	2003-12-03
WO2002070457A1 (en)	2002-09-12
SE0302361L (sv)	2003-09-03
CH695982A5 (de)	2006-11-15
ECSP034760A (es)	2003-10-28
EE200300419A (et)	2004-02-16
SE526598C2 (sv)	2005-10-18
ES2201942B2 (es)	2004-12-16
EA005768B1 (ru)	2005-06-30
HUP0303341A3 (en)	2007-03-28
OA12494A (en)	2006-05-24
GB2389851B (en)	2005-05-25
US7384983B2 (en)	2008-06-10
PL363840A1 (pl)	2004-11-29
FI20031191A7 (fi)	2003-08-25
HUP0303341A2 (hu)	2004-01-28
AP2003002855A0 (en)	2003-08-20
JP2004525912A (ja)	2004-08-26
AT414238B (de)	2006-10-15
US20050209341A1 (en)	2005-09-22
ES2305221T3 (es)	2008-11-01
LV13119B (en)	2004-06-20
SE0302361D0 (sv)	2003-09-03
LU91038B1 (fr)	2003-09-11

Publication	Publication Date	Title
CY2015028I1 (el)	2016-07-27	Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
DE60234125D1 (de)	2009-12-03	E inhibitoren
DK1425586T3 (da)	2008-02-11	Massemarkörer
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
PT1370553E (pt)	2006-09-29	Inibidores de rhoquinase
DE60223654D1 (de)	2008-01-03	Resistzusammensetzung
IS6915A (is)	2003-08-15	Lyfjablanda
BR0210619A (pt)	2006-05-23	composição
DE60236243D1 (de)	2010-06-17	Positiv arbeitende Resistzusammensetzung
IS7081A (is)	2003-12-16	Lyfjablanda
FI20031191L (fi)	2003-08-25	Monoamiinin takaisinoton estäjä
DE50202147D1 (de)	2005-03-03	Werbeträger
DE60205430T2 (de)	2006-06-14	Ventiltriebanordnung
EP1609479A4 (en)	2010-01-20	Tumorigenesis INHIBITOR
DE60201319D1 (de)	2004-10-28	Trisazoverbindung
ITTO20020744A0 (it)	2002-08-23	Composizione
ITTO20020745A0 (it)	2002-08-23	Composizione
ATA12432001A (de)	2003-03-15	Werbeträger
AT500276B1 (de)	2006-06-15	Radschwenksystem
SE0101203D0 (sv)	2001-04-03	New composition
SE0101788D0 (sv)	2001-05-21	New composition
ES1050080Y (es)	2002-06-16	Postelete informativo
SE0101777D0 (sv)	2001-05-18	Motionsredskap
ITVI20010003U1 (it)	2002-07-25	Trampolo
SE0102059D0 (sv)	2001-06-08	New combination

Legal Events

Date	Code	Title	Description
2008-08-31	MA	Patent expired